Biomagnetics Provides an Update to its Investors and Shareholders

Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, communicates to its shareholder base.

Biomagnetics would like to update our shareholders and the investment community, and express our gratitude to those of you who have given support. We are committed to bring our revolutionary diagnostic system to the market place.

Clayton Hardman, President of Biomagnetics states, “During the past few months Biomagnetics has been quiet while we were trying to raise the necessary capital to complete the engineering and bring our advanced Integrated Optical Bio Sensor to market. This has been a very long process, but now we believe we have found a financial partner who shares our vision and excitement.” Mr. Hardman continues, “Our goal over the next several weeks is to give details of financing, operations in China, engineering, and technology agreements.”

About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company is currently developing a waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.

Biomagnetics Diagnostics (CE) (USOTC:BMGP)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024